Education
About Us
Working with TipRanks
Follow Us
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
DAWN Analyst Ratings
Strong Buy
8 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
DAWN Stock 12 Month Forecast
Average Price Target
$34.13
▲(316.73% Upside)
| Highest Price Target$43.00 | Average Price Target$34.13 | Lowest Price Target$24.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
JonesTrading
Reiterated
03/11/25
J.P. Morgan
Reiterated
03/04/25
Piper Sandler
Reiterated
02/26/25
Needham
Reiterated
02/26/25
Bank of America Securities
Reiterated
02/26/25
H.C. Wainwright
Reiterated
02/25/25
TD Cowen
Reiterated
02/25/25
Oppenheimer
Reiterated
02/25/25
Goldman Sachs
Reiterated
02/10/25
Wedbush
$33→$32
Buy
290.72%
Upside
Reiterated
07/30/24
Day One Biopharmaceuticals (DAWN) PT Lowered to $32 at WedbushWedbush analyst Robert Driscoll lowered the price target on Day One Biopharmaceuticals (NASDAQ: DAWN) to $32.00 (from $33.00) while maintaining a Outperform rating.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
JonesTrading
Reiterated
03/11/25
J.P. Morgan
Reiterated
03/04/25
Piper Sandler
Reiterated
02/26/25
Needham
Reiterated
02/26/25
Bank of America Securities
Reiterated
02/26/25
H.C. Wainwright
Reiterated
02/25/25
TD Cowen
Reiterated
02/25/25
Oppenheimer
Reiterated
02/25/25
Goldman Sachs
Reiterated
02/10/25
Wedbush
$33→$32
Buy
290.72%
Upside
Reiterated
07/30/24
Day One Biopharmaceuticals (DAWN) PT Lowered to $32 at WedbushWedbush analyst Robert Driscoll lowered the price target on Day One Biopharmaceuticals (NASDAQ: DAWN) to $32.00 (from $33.00) while maintaining a Outperform rating.
DAWN Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
10
12
6
15
15
Buy
2
1
2
2
2
Hold
1
1
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
14
8
18
18
Each month's total comprises the sum of three months' worth of ratings.
DAWN Financial Forecast
DAWN Stock Forecast FAQ
What is DAWN’s average 12-month price target, according to analysts?
Based on analyst ratings, Day One Biopharmaceuticals’s 12-month average price target is $34.13.
What is DAWN’s upside potential, based on the analysts’ average price target?
Day One Biopharmaceuticals has 316.73% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is DAWN a Buy, Sell or Hold?
Day One Biopharmaceuticals has a consensus rating of Strong Buy which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.
What is Day One Biopharmaceuticals’s price target?
The average price target for Day One Biopharmaceuticals is $34.13. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $43.00 ,the lowest forecast is $24.00. The average price target represents 316.73% Increase from the current price of $8.19.
The highest analyst price target is $43.00 ,the lowest forecast is $24.00. The average price target represents 316.73% Increase from the current price of $8.19.
What do analysts say about Day One Biopharmaceuticals?
Day One Biopharmaceuticals’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of DAWN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.